September 16, 2021
CV Safety of Prostate Cancer Therapies ‘Remains Unresolved’: PRONOUNCE
Salim Hayek MD, FACC gives fresh perspective on the null results of the PRONOUNCE trial on cardiotoxic prostate cancer therapies.
Salim Hayek MD, FACC gives fresh perspective on the null results of the PRONOUNCE trial on cardiotoxic prostate cancer therapies.